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Ubiquitin (Ub) is a small protein modifier that is covalently attached to the -amino group of
lysine residues of protein substrates, generally targeting them for degradation. Due to the emer-
gence of specific anti-diglycine (-GG) antibodies and the improvement inMS, it is now possible
to identify more than 10 000 ubiquitylated sites in a single proteomics study. Besides cataloging
ubiquitylated sites, it is equally important to unravel the biological relationship between ubiqui-
tylated substrates and the ubiquitin conjugationmachinery. Relevant to this, we discuss the role
of affinity purification-MS (AP-MS), in characterizing E3 ligase-substrate complexes. Recently,
such strategies have also been adapted to screen for binding partners of both deubiquitylating
enzymes (DUBs) and ubiquitin-binding domains (UBDs). The complexity of the “ubiquitome”
is further expanded by the fact that Ub itself can be ubiquitylated at any of its seven lysine
residues forming polyubiquitin (polyUb), thus diversifying its lengths and topologies to suit a
variety of molecular recognition processes. Therefore, applying MS to study polyUb linkages
is also becoming an emerging and important area. Finally, we discuss the future of MS-based
proteomics in answering important questions with respect to ubiquitylation.
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1 Introduction
Highly conserved among the eukaryotes, ubiquitin (Ub) is
an 8.5 kDa protein that covalently modifies protein sub-
strates so as to regulate their stability, localization, and ac-
tivity [1]. Importantly, such regulation contributes to protein
turnover, endocytosis, immune response, transcription, and
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DNA repair [2, 3]. Ubiquitin consists of 76 amino acids. Dur-
ing ubiquitylation, an isopeptide bond is formed between
the C-terminus diglycine (di-Gly) of Ub and the -amino
group of the targeted Lys residue. Although rare, it is also
possible for an N-terminal amine or a Cys residue to be
ubiquitylated. Analogous to protein phosphorylation, which
is regulated by kinases, phosphatases and substrate-binding
domains, ubiquitylation is finely orchestrated by a similar
writer/eraser/reader paradigm (Fig. 1). First, three classes
of enzymes are required for ubiquitylation: Ub activating en-
zyme (E1), Ub conjugating enzyme (E2), and Ub ligase E3 [4].
They are the “writers”. The human genome encodes two E1,
approximately 40 E2 and 700 E3 enzymes [5], whereby the
∗Additional corresponding author: Professor Albert J. R. Heck,
E-mail: a.j.r.heck@uu.nl
Colour Online: See the article online to view Figs. 1–4 in colour.
C© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.proteomics-journal.com
Proteomics 2013, 13, 526–537 527
Figure 1. Conceptual simi-
larities between regulatory
networks involved in phos-
phorylation and ubiquitylation.
Generally, regulation of PTMs
follows a reader/writer/eraser
paradigm where the “writers”,
such as kinases or E3 ligases
catalyze the covalent transfer
of modifying moieties (phos-
phates or ubiquitin) onto target
proteins while the “erasers”
such as phosphatases or deu-
biquitylating enzymes (DUBs)
reverse the modifications. The
modifying moieties serve as
marks that are then interpreted
by “reader” modules such as
SH2’s, WW’s, or FHA’s that
specifically recognize phos-
phorylated motifs or ubiquitin-
binding domains (UBDs) that
recognize ubiquitin tags of dif-
ferent lengths and topologies.
E2 and E3 enzymes confer substrate specificity. Ubiquitin
can be attached to one or multiple Lys residues in proximity,
forming monoubiquitin (monoUb), or multiple monoubiq-
uitin, respectively. Moreover, all seven internal Lys residues
(K48, K63, K6, K11, K27, K29, and K33) of an Ub moiety
can be further conjugated to form polyubiquitin (polyUb) [6].
Ubiquitylation can be reversed by approximately 100 deu-
biquitylating enzymes (DUBs), the “erasers” [7]. Meanwhile,
the “readers” consist of approximately 20 ubiquitin-binding
domains (UBD) that are used for Ub binding and signal
interpretation [8]. Based on the sheer numbers and diver-
sity of writers, erasers, and readers, it can be hypothesized
that ubiquitylation is as fine tuned and tightly regulated as
phosphorylation.
2 Proteomics of PTMs
One strength of MS-based proteomics is its capability to glob-
ally and simultaneously analyze PTMs, which are known to
expand the physicochemical and functional diversity of pro-
teins beyond approximately 20 000 encoding genes. Ideally,
PTM-oriented proteomics is capable of deciphering the local-
ization of every PTM and precisely quantifying its level and
occupancy within a defined cellular space and time. In real-
ity, among the 552 naturally occurring PTM records in the
RESID database [9], only phosphorylation [10], N-terminal,
and Lys acetylation [11] and glycosylation [12] are studied en
masse. Due to their generally low abundance and diverse
chemistries, each PTM necessitates dedicated enrichment
and analysis procedures.
2.1 Protein level enrichment of ubiquitylated
proteome
Rational designs exploiting the chemistry of ubiquitin for
enriching ubiquitin-modified proteins/peptides have yet to
emerge. However, since Ub is a protein, methods tailor made
for affinity purification of proteins can also be applied to cap-
ture the ubiquitin-modified proteome (ubiquitome). Gener-
ally, these methods apply either (i) epitope-tagged ubiquitin,
(ii) Ub-specific antibodies, or (iii) UBD domains. A common
pitfall of such methods is nonspecific binding, which is di-
minishable by stringent washing steps or by referring to a
contaminant list obtained from control experiments. Still,
another more confounding problem arises from a wide vari-
ety of undesirable secondary binders that interact specifically
with Ub or Ub proteins. Fortuitously, trypsin cleaves after
R74 of ubiquitin, leaving the C-terminal di-Gly intact on the
modified Lys [13]. FollowingMS/MS, this di-Gly remnant can
be identified for localizing and validating the ubiquitylation
sites.
Peng et al. pioneered the use of His-tagged Ub to target the
Ub-proteome in yeast. This resulted in the identification of
1075 Ub protein candidates, and 110 Ub sites [13]. Different
epitope tags have been explored to tag Ub, including FLAG,
HA, Myc, and biotin tags [14]. Currently, the His-tagged Ub
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is the most widely applied technique partly because the co-
ordination of His-rich motifs to immobilized Ni2+ ions is
unaffected by denaturing conditions [15]. Performing affinity
purification under denaturing conditions has benefits as it
(i) reduces nonspecific protein–protein interactions and (ii)
inhibits DUBs [16]. To achieve even cleaner purification, dif-
ferent epitope tags have been fused to create a tandem-affinity
purification tag (TAP-tag) that allows immunoprecipitations
to be performed in two consecutive steps [17]. Applying His-
biotin-tagged Ub on a yeast sample under fully denaturing
conditions, Tagwerker et al. identified 285 Ub protein can-
didates [18], with a significant reduction in contaminants
compared to Peng et al.’s earlier study [13]. Danielsen et
al. reported, using Strep-HA-tagged Ub, 753 Ub sites from
an U2OS cell line [19]. Recently, FLAG-His-tagged Ub was
expressed in a K0-Ub yeast mutant in which all seven inter-
nal Lys in Ub were replaced with Arg [20], preventing the
formation of polyUb. This allows the steady-state level of Ub
substrates to accumulate against proteasomal degradation.
In addition, it improves the dynamic range of Ub proteins
against Ub, which is themost ubiquitylated substrate in wild-
type yeast. This strategy enabled Oshikawa et al. to identify up
to 1392 Ub sites. However, the epitope-tagging approach has
its caveats, as overexpression of exogenous, taggedUbmay af-
fect cellular physiology. Besides, endogenousUbcan compete
with tagged Ub for ubiquitylation sites. In yeast, endogenous
Ub can be easily knocked out, but this is more difficult in
mammalian cells as they harbor four loci for Ub [21]. In con-
trast to epitope tagging, Ub-specific antibody-based strategies
can be applied to samples not amenable for genetic engineer-
ing, such as tissues or primary cells. These antibodies, such
as FK2 [22], recognize only conjugated Ub but not the uncon-
jugated forms, the latter being far more abundant [23]. Better
still, the binding capacity of the FK2 antibody is unaffected
by denaturing conditions as 345 Ub proteins were purified
in 8 M urea, as demonstrated by Matsumoto et al. [24]. Re-
cently, K11, K48, and K63 linkage-specific antibodies have
emerged [25–27], though not yet thoroughly tested.
Eukaryotic cells evolved more than 20 different UBD fam-
ilies for recognition and binding to ubiquitin modifications.
Most of these UBDs have weak affinity for polyUb [8, 28]. To
use UBDs for enrichment of Ub proteins, multiple UBDs
were fused to create tandem repeated ubiquitin-binding en-
tities to enhance binding avidity [29, 30]. Shi et al. reported
the isolation of approximately 300 ubiquitination sites with
four tandem ubiquilin-1 fused to a GST tag [31]. Despite the
functional heterogeneity of Ub signaling, the diversity and
combinatorial capability of UBDs present opportunities to
isolate Ub proteins involved in a specific pathway. In recent
work, Akimov et al. made ingenious use of different UBDs
by first depleting abundant Lys-48 polyUb protein conjugates
using GST-UBA domains of human Rad23A (hHR23A). The
pre-cleaned lysates were then incubated with recombinant
GST-taggedUBDs from the endocytic adaptor proteins Eps15
and Epsin-1, so as to unravel the role of ubiquitin signaling
in the EGFR network [32].
2.2 Peptide level enrichment of ubiquitylated
proteome
For Ub proteins that are enriched at the protein level, the en-
suing proteolytic process often leads to low-abundant di-Gly-
modified peptides and highly abundant unmodified peptides.
Thus, unmodified peptides tend to suppress di-Gly-modified
peptides during MS analysis. To address these shortcom-
ings, Xu et al. developed a monoclonal antibody (i.e. GX41)
that specifically recognizes peptides harboring the di-Gly-
modified Lys, but not internal Gly-Gly-Lys residues [33]. Us-
ing GX41 for peptide-based enrichment, Wagner et al. identi-
fied 11 054 endogenous ubiquitylation sites from trypsinized
cell lysate [34]. Concurrently, by using a commercial mon-
oclonal antibody, Kim et al. also reported approximately
19 000 Ub sites [35]. These studies demonstrate that enrich-
ment at the peptide level is efficient, requiring only a single
step of affinity enrichment, and is amenable to samples from
any cells or tissues [36]. More recently, to study the effects
of proteasome inhibition by MG-132 and DUB inhibition by
PR-619, Udeshi et al. employed limited pre-fractionation of
peptides bySCXprior to enrichmentwith anti-di-Gly remnant
antibodies [37]. This combination resulted in the identifica-
tion of 5533 di-Gly-modified peptides, an increase of threefold
to fourfold compared to unfractionated samples.
2.3 Ubiquitomics: Caveats and challenges
Main challenges for ubiquitomics arise from the low steady-
state levels of protein ubiquitylation, attributed to its (i)
inherently low stoichiometry, (ii) rapid degradation by the
proteasomal machinery, and (iii) deubiquitylation by DUBs.
By treating cells with proteasome inhibitors such as MG132
during sample preparation, the accumulation of Ub sub-
strates can be enhanced [38]. DUBs can be inhibited by chem-
ical inhibitors such as N-ethylmaleimide, choloroacetamide,
iodoacetamide (IAA) or 1,10-o-phenanthroline [7, 39] or by
performing experiments under fully denaturing conditions.
However, since DUBs are associated with Ub molecules, it
is difficult to fully inactivate them [16]. Also, there is still
some confusion about the specificity of trypsinization of Ub.
Previously, it was reported that the longer -LR74GG rem-
nant (+383.228 Da), which originates from the miscleav-
age of the R74 residue, can be detected together with the
more common di-Gly remnant [40]. More recently, upon sys-
tematic analyses of Ub conjugates, the -LGRR remnant was
rarely identified [41]. Instead, R74 was shown to be the most
accessible residue for trypsin in both native and denatur-
ing conditions [42, 43]. Similarly, it was claimed that trypsin
cleaves C-terminal to ubiquitylated Lys residues of synthetic
Ub [44]. This was, however, contradicted by observationmade
by Seyfried et al. [41], supported by recent large-scale stud-
ies showing that trypsin does not cleave the vast majority of
di-Gly-modified lysines [34–36]. Thus, the presence ofmiscle-
avage at a di-Gly-modified lysine can, in fact, provide further
confidence in site localization.
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It is noteworthy that, Ile (113.084 Da), Leu (113.084 Da),
Asp (115.027 Da), and Asn (114.043 Da) havemolecular mass
very similar to di-Gly (114.043 Da). Peptides containing these
amino acids adjacent to an internal Lys can be mis-assigned
as Ub peptides if they are analyzed withMSwith lowmass ac-
curacy and resolution. Except for Asn, which is indistinguish-
able from di-Gly by mass, this ambiguity can be resolved by
acquiring selected precursors in SIM scan, or by using MS
with higher resolution and mass accuracy. Assignment of
Ub sites can be improved by complementing fragmentation
by collision-induced dissociation with electron transfer dis-
sociation [45] to obtain unambiguous product ion series or
further confirmed by SRM. Excessive alkylation by IAA has
been reported to potentially induce an artifact having the exact
chemical composition (C4H6N2O2) as di-Gly [46]. This prob-
lem can be solved by replacing IAA with chloroacetamide
or by reducing the concentration of IAA. Nonetheless, even
with unprecedented mass accuracy, resolution, and complete
product ion series, not all Ub peptides can be identified with
absolute confidence. For example, NEDD8 and ISG15 mod-
ifications also produce di-Gly remnants on modified lysines
after trypsinization, and are therefore indistinguishable by
MS from Ub. Moreover, identification of the di-Gly remnant
itself is insufficient to reveal if the modified lysine is mono-
or polyubiquitylated.
Recently, Shi et al. described how different database search
algorithms contribute to the discrepancy in sensitivity and
specificity in ubiquitome analysis [21], even when followed by
peptide validation strategies such as target-decoy search [47]
and Percolator that uses semi-supervisedmachine learning to
discriminate between correct and decoy spectrum identifica-
tions [48]. Based on our past experiences with PTM analysis,
especially phosphorylation, different algorithms written for
modification site localization scoring [49] can also be use-
ful for Ub site determination. As the emerging discipline
of ubiquitomics presents new challenges, drafting consensus
guidelineswithin the community for data analysis, validation,
and reporting would be very welcome.
3 Ubiquitin chain linkages
The identification of ubiquitylation sites by di-Gly signatures
on substrates, though useful, does not directly reveal the
full picture since ubiquitin moieties can form poly-chains
of various lengths and topologies, each giving rise to a wide
variety of molecular signals [8]. Ikeda et al. classified Ub
chains into four distinct groups [50] (Fig. 2). In homotypic
polyUb chains, Ub molecules are sequentially conjugated to
another Ub molecule on lysine residues of a fixed position.
In mixed-linkage chains, different lysine residues in the
Ub monomers are conjugated, thus forming forks or bifur-
cations. In some cases, polyUb chain can also incorporate
other ubiquitin-like (Ubl) modifiers, such as SUMO and
NEDD8, forming heterologous Ub chains. Finally, multiple
monoubiquitin that are spatially close can be considered as
Figure 2. Nature’s variety of ubiquitin chain linkages. Illustrated
are the ubiquitin chain linkages as proposed by Ikeda et al. [50].
(A) Homotypic linkages consist of typical chains such as Lys 48-
and Lys 63-linked Ub chains or atypical chains such as Lys 6-,
Lys 11-, Lys 27-, Lys 29-, and Lys 33-linked chains. (B) Mixed-
linkage chains are formed by different lysines for consecutive
Ub conjugation, resulting in forked chains. (C) Heterologous
chains are produced when Ub is conjugated to other ubiquitin-
like proteins such as small ubiquitin-like modifier (SUMO) and
(D) Multiple monoubiquitination moieties on the same protein
substrate.
Ub signals. The precise chain length and topology of polyUb
chains are crucial for recognition by different “readers”
that subsequently determine the fates of the ubiquitylated
substrates. For instance, monoUb has been shown to control
diverse cellular processes such as receptor transport, viral
budding, andDNA repair [51]. Homotypic K48 polyUb chains
with at least four Ub moieties are considered a canonical
signal for proteasomal degradation by 26S proteasomes [52].
Meanwhile, K63 polyUb acts in a wide variety of nonprote-
olytic processes such as protein sorting, DNA repair, kinase
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activation, as well as translational control [50], though it may
also target substrates to proteasomal degradation [53]. To
further add to the complexity, it has also been reported that
substrates that are degraded in the ubiquitin fusion degra-
dation pathway may be tagged with mixed chains that are
initiated by K29 but elongated with K48-linked chains [54]. In
another atypical Ub chain linkage, ubiquitins are linked lin-
early by C-terminal Gly to amino-terminal Met residue of the
substrate-conjugated ubiquitin [55]. This linear Ub linkage
was demonstrated to be essential in nuclear factor-kappa B
activation and cellular responses to inflammatory cytokines
[56, 57].
3.1 Quantifying and deciphering ubiquitin chain
linkages with MS
Upon trypsinization, both monoUb and polyUb produce
linkage-specific peptides with characteristic mass and se-
quences. These signature peptides can be used to iden-
tify and quantify individual chain linkages. Based on semi-
quantitative spectral counts, all seven Lys residues have been
found to form Ub–Ub linkages, with the following relative
order of abundance: K48 > K11 and K63  K6, K27, K29,
and K33 in Saccharomyces Cerevisiae [13]. To achieve precise
and accurate quantitation of Ub linkages, another MS-based
strategy has been developed that combines absolute quantifi-
cation of proteins and their modifications (AQUA) [58] with
SRM [59]. This so-called Ub-AQUA-SRM method comprises
two basic steps. First, isotopic variants of di-Gly-modified
Ub peptides corresponding to substrate-, site- and linkage-
specific native peptides, are synthesized as internal standards.
These peptides are chemically identical to their native coun-
terparts, but are distinguishable by their mass. Second, these
internal standards are spiked, at a defined amount, into a
sample, which is later trypsinized. This digested sample is
then subjected to LC-SRM-MSanalysiswhere co-elutednative
di-Gly-containing peptides and internal standards are mon-
itored by SRM to quantify Ub linkages. This approach is
very useful, albeit only to identify and quantify known chain
linkages.
Ub-AQUA-SRM has stringent pre-requirements. Com-
plete digestion of target proteins is essential, therefore
digestion conditions have to be carefully optimized [60]. By
systematic optimizations, Xu et al. found that for in-solution
digestion, trypsinization in 2M urea is themost efficient [61],
while Phu et al. used 20 ng/L trypsin diluted in 50 mM
ammonium bicarbonate in 5% ACN at pH 8.0 to yield the
best results [62]. In addition, peptides representing each
Ub-linkage is systematically characterized beforehand for
optimal detection and quantitation [61, 62]. It was found that
even under optimal conditions, partially digested peptides
were observed at K63 and K33 cleavage sites. These miscleav-
ages were attributed to acidic residues flanking K63 and K33.
The peptides for K6 linkage,meanwhile, contain aN-terminal
Met that is susceptible to oxidation to form sulfoxide or
sulfone. This complicates quantitation as the distribution of
oxidation states cannot be precisely determined. To alleviate
this problem, peptides can be treated with 5% formic acid
or 5% hydrogen peroxide to fully oxidize Met residues.
Finally, the K29-linkage peptide [SK(-GG)IQDK] is very
hydrophilic and therefore not well retained by C18 materials.
Lowering the organic content of loading buffer improves
binding.
Notwithstanding these practical challenges, the Ub-
AQUA-SRM method has been successfully applied to
measure linkages of total Ub conjugates in yeast, revealing
that the ratio of K6:K11:K27:K29:K33:K48:K63 linkages was
11%:35%:7%:4%:1%:30%:11% [63], in agreement with the
previously reported data based on spectral counts. This
technique was also applied to quantify polyUb topologies
attached to the EGF receptor [64] and cyclin B1 [59]. While the
EGF receptor is modified with approximately 49%mono-Ub,
40% K63, 6% K48, 3% K11, and 2% K29 linkages, cyclin B1
was found to be conjugated by mono-Ub and short polymers
linked by K11, K48, and K63 during in vitro ubiquitylation.
Although the stoichiometry of ubiquitin linkages for selected
proteins can be determined by Ub-AQUA-SRM, some
structural information is missing, especially for forked
linkages [16]. To resolve this, a so-called middle-down MS
approach was proposed for analyzing Ub-chain linkages [43].
This strategy consists of three steps. In step 1, limited prote-
olysis of target proteins is performed with trypsin under well-
controlled native condition so that only the R74 site is cleaved.
Therefore after digestion, two types of Ub peptides are pro-
duced. The first type is namedUbR74, as it comprises the first
74 residues of Ub without any di-Gly remnants. These pep-
tides either originate from monoUb or the distal end-cap of
polyUb. The second type is namedUbR74-GG because it con-
tains one ormore di-Gly remnants on at least one of the seven
Lys residues of Ub. UbR74-GGs originate from the internal
units of polyUb. In step 2, the tryptic lysate is analyzed using
LC-MS/MS. In step 3, the extracted ion chromatograms
from different charge states of both UbR74 and UbR74-GG
are computed and compared. This is possible because both
UbR74 and UbR74-GG co-elute in C8 chromatography and
ionize with similar efficiency despite the additional di-Gly
tags. This allows both species to be directly quantified and
compared in the same MS survey scans without spiking in
any isotopic internal standards. In the simplest instance,
the ratio between UbR74 and UbR74-GG reflects the actual
length of homotypic linkages. Based on the ratio of UbR74
and different variants of UbR74-GG, this analysis can be
mathematically extended to other chain linkages to reveal
their lengths and topologies.
Independently, Kaiser et al. developed ubiquitin protein
standard absolute quantification [65]. Ubiquitin protein stan-
dard absolute quantification shows two novel aspects com-
pared to Ub-AQUA-SRM although both methods measure
Ub linkages with LC-MS/MS after trypsinzation of Ub pro-
teins. First, specialized UBDs are used to enrich separately
different variants of Ub so as to determine the concentration
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Figure 3. Schematic overview
of the ubiquitin proteasome
system (UPS). During Ub ac-
tivation, an E1 enzyme forms
a thioester bond between its
catalytic cysteine and an Ub
molecule in an ATP-dependent
manner. Then, E1 enzyme binds
to an E2 conjugating enzyme,
to which the Ub is transferred.
Subsequently, E2 enzymes bind
to E3 ligases and pass acti-
vated Ub to a protein sub-
strate also bound to E3. While
mono- and multi-ubiquitylated
substrates are subjected to non-
proteasomal regulation, polyu-
biquitylated substrates are de-
graded by the 26S proteasome.
of monoUb and free Ub pools, which are not quantified in
Ub-AQUA-SRM. Furthermore, heavy isotope-labeled protein
that represents each of these three major ubiquitin popula-
tions is spiked in as standards instead. By using protein stan-
dards [66] rather than peptide standards, one can account for
the loss of proteins through sample processing, fractiona-
tion, or DUB activity, to achieve more precise determination
of absolute abundance.
4 Ubiquitin network: Wiring by writers,
readers, and erasers
The afore-mentionedMS-centric strategies enable large-scale
identification of ubiquitin sites and their chain linkages, but
fail to describe the complex ubiquitin network that is char-
acterized by the writer/eraser/reader paradigm. As described
earlier, the “writers” comprise a conjugation machinery of
E1-E2-E3 enzymes. An E1 enzyme forms a thioester bond
between its catalytic cysteine and an Ub molecule in an ATP-
dependent manner. Ub charging induces structural changes
in E1 that subsequently promote binding of E1 to an E2 con-
jugating enzyme, to which Ub is transferred. The specificity
of the ubiquitylation is then provided by the E3 ligase en-
zyme, which physically interacts with both the target sub-
strate and the activated ubiquitin–E2 complex, to complete
the transfer of ubiquitin to the target protein (Fig. 3). Several
rounds of ubiquitin conjugation can produce long chains of
ubiquitin moieties (polyubiquitylation), the first of which is
covalently bound to the substrate. At this point, the polyu-
biquitylated protein must also be able to interact with the
proteasome or with shuttling factors that deliver it to the pro-
teasome; whereasmonoubiquitylated andmultiubiquitylated
proteins have nonproteolyic fates. The human genome is es-
timated to encode for more than 700 E3 ligases, which are
classified in four major classes on the basis of their charac-
teristic structural motif and by the presence of unique do-
mains: the RING-finger proteins, HECT-domain proteins or
U-box-type and PHD finger-type [67,68]. Many multisubunit,
RING-finger type ubiquitin ligases contain a cullin (Cul) pro-
tein subunit, a name derived from the ability of cullin RING
ubiquitin ligases (CRLs) to “cull” or sort substrates for degra-
dation. In mammals, there are six different CRLs, including
the SKP1–CUL1–F-box protein (SCF) complex.
4.1 Identification of E3 ligases and substrate
interaction
Matching each ubiquitin E3 ligase to its respective substrates
helps unravel mechanism and physiology of the ubiquitin
system. It is believed that most modifying enzymes, such as
kinases, interact transiently with their substrates in a “hit-
and-run” manner [69]. Therefore, it is more feasible to assay
the products of ligase activity rather than ligase–substrate in-
teraction itself. An E3 ligase can be perturbed, for instance
by RNAi, chemical inhibitors or genetic manipulations, and
subsequently the perturbed samples and the controls may be
evaluated by quantitative MS for any changes. If the ubiqui-
tylated substrates are degraded by the proteasomal pathway,
the differential levels of proteins can be used as readouts for
putative substrates. Burande et al. created amyeloid leukemia
cell line expressing an ASB2 BC box mutant (ASB2LA)
that is unable to interact with the Elongin BC complex,
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Figure 4. Defining ubiquitin-regulating signaling networks by affinity purification and MS. A schematic of an HA-flag-tagged F-box protein
(FBPs) used for affinity-based MS studies featuring -TrCP as FBP. SCF ligases are composed of Skp1, Cullin 1, a RING-finger protein (Rbx1)
and a variable component known as F-box protein. Cul1 is a scaffold protein that interacts via its N-terminus with the adaptor protein
Skp1, and via its C-terminus with the RING-finger protein Rbx1, as well as a specific E2 enzyme. Skp1, in turn, binds to the F-box protein.
F-box proteins recognize and recruit specific substrates that are subsequently ubiquitylated by E2 enzymes. The WD40 repeats -propeller
structure of -TrCP specifically recognize a diphosphorylated motif with the consensus DpSGXX(X)pS, known as phosphodegron.
resulting in the accumulation of ubiquitylated proteins. Label-
free proteomics was then used to compare proteomes of wild-
type and mutant cell line [70]. Recently, Koo et al. reported
on a membrane E3 ligase, RNF43, which is important in
regulating the turnover of receptors involved in Wnt signal-
ing. By using cell surface biotinylation to isolate membrane
proteins followed by label-free quantitative MS, they demon-
strated that LRP5, LRP6, and frizzleds are downregulated
upon doxycycline-driven induction of RNF43 [71]. Neverthe-
less, these protein level-based assays require extensive valida-
tion due to the lack of evidence on ligase–substrate interac-
tion and ubiquitylated sites, as proteins can also be indirectly
downregulated upon transcriptional repression, or degraded
by cellular proteases. One possible way to address this is to
enrich for ubiquitylated peptides prior to quantitative MS. In
one application, MLN4924, a chemical inhibitor, was used to
inhibit the NEDD8 E1 enzyme, Nae1 [72]. The inhibition of
Nae1 led to the inactivation of CRLs that are allosterically ac-
tivated by neddylation [73]. Subsequently, ubiquitylated pep-
tides from untreated controls andMLN4924 treated were sep-
arately enriched by anti-di-Gly remnant antibodies followed
by quantitativeMSusing SILAC.A similar approachwas used
to study HRD1, an E3 ligase implicated in rheumatoid arthri-
tis. In this study, RNAi was used to knock down HRD1, then
cell lysates from both treated untreated cells were pooled, fol-
lowed by enrichment for Ub-proteins and Ub-peptides prior
to MS analysis [74].
Contrary to the conventional belief, ligase–substrate inter-
actions can be partially retained upon IP. This feature allows
us to employ affinity purification-mass spectrometry (AP-MS)
to identify ubiquitin ligases targeting a specific substrate and
vice versa. For instance, using AP-MS, Yaron et al. identified
-TrCP as the receptor component of the ubiquitin ligase
that targets IB for proteasomal degradation [75]. After this
study, similar AP-MS approaches have led to the identifica-
tion of additional substrates of SCF-TrCP [76–78]. SCF-TrCP
belongs to themulti-subunit SCF ligase subfamily [68], whose
members are composed of the invariable core subunits Cul1,
Rbx1, and Skp1 and the variable subunit F-box protein (FBP)
that determines substrate specificity (Fig. 4). Cul1 is a scaf-
fold protein that interacts via its N-terminus with the adaptor
protein Skp1, and via its C-terminus with the RING-finger
protein Rbx1, which in turn binds to a specific ubiquitin-
conjugating enzyme. Skp1 interacts with the F-box domain
of one of approximately 70 FBPs, which recruit substrates via
protein–protein interaction (PPI) domains such as WD-40
and leucine-rich repeats. The WD40 repeats of -TrCP form
a -propeller structure that specifically recognizes a diphos-
phorylated motif with the consensus DpSGXX(X)pS, known
as phosphodegron. Due to the modular structure of these
ubiquitin ligases, tagging the actual substrate-binding sub-
unit is expected to give the highest chance of success in
identifying their specific substrates. Recently, this approach
has led to the identification of novel substrates of SCF-TrCP
[79], SCFFBXO1/cyclinF [80, 81], SCFFBXW7 [82], SCFFBXO6 [83],
SCFFBXO25 [84], SCFSkp2, and SCFFBXL5 [85]. Two sequential
immunoprecipitations are often used in these studies to re-
duce the co-purification of unspecific contaminants, although
this may result in the loss of weakly interacting partners. One
possible way to address this problem is to employ quantita-
tive MS and analyze protein abundance in an experimental
sample relative to a negative control [86]. Appropriate neg-
ative controls are FBPs lacking the F-box domain which, as
a result, are unable to bind the other SCF subunits [85], or
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FBPs with specific point mutations in the WD40 repeats that
fail to bind their substrates [87].
4.2 Identification and characterization of DUBs
Conjugated Ub moieties can be removed by DUBs, which
are cysteine proteases or metalloproteases. DUBs comprise
five major classes, based on their catalytic domain struc-
ture: ubiquitin C-terminal hydrolases (UCHs), ubiquitin-
specific proteases (USPs), ovarian tumor proteases (OTUs),
Machado-Joseph disease proteases, and JAB1/MPN/Mov34
metalloenzymes (JAMMs). DUBs are essential for (i) activat-
ing ubiquitin proproteins, (ii) recycling of ubiquitin adventi-
tiously trapped in inactivatable forms, (iii) reversing ubiquity-
lation from target proteins, and (iv) regenerating of monoUb
from free polyUb chains [88]. DUBs are less well charac-
terized compared to ligases, though approximately 100 hu-
man DUBs are estimated to exist, by in silico methods [89]
and activity-based protein profiling [90]. In activity-based pro-
tein profiling, epitope-tagged Ub are used as probes to cap-
ture DUBs. These synthetic probes harbor compounds such
as vinyl methylsulfone, vinyl methylester, alkyl halides, and
vinyl cyanides as substitutes for C-terminal Gly residue of
Ub. These thiol-reactive groups can act as “suicide” sub-
strates when positioned within the DUB active site. Sub-
sequently, probe-DUB complexes can be purified by their
epitope tags followed by identification with LC-MS/MS. This
approach has been used to capture 23DUBs frommouse lym-
phoma cell lysates, at the same time, discovering new gene
products (Otubain) that contain the ovarian tumor domains
[91].
Despite their well-defined identities and biological roles,
very little is known about the enzymatic targets and modes of
regulation for DUBs [92]. Large-scale PPI screens have been
performed on 75 of the 95 DUBs encoded by the human
genome in order to identify stably associated interacting pro-
teins [93]. Ensuing this, the specific biological functions of
the DUBs could be partly inferred from interacting protein
partners based on the principle of “guilt-by-association” [94].
Indeed, this study led to the identification of 774 unique
high-confidence candidate interacting proteins, one-third of
them being involved in protein turnover, transcription, RNA
processing, or DNA damage response, providing insights
into the possible biological functions and regulatory mech-
anisms of DUBs. Besides, 26 DUBs were found to asso-
ciate with one or more proteins that contain domains as-
sociated with ubiquitin conjugation, including HECT and
Cullin-based E3 ubiquitin ligases, suggesting the existence
of larger ubiquitin-regulating signaling scaffolds, enabling
cross-regulation within the ubiquitin system.
In a multifaceted study, the entire family of 20 puta-
tive DUBs in Schizosaccharomyces pombe was studied by de-
termining their endogenous localizations, in vitro activity,
and PPIs [94]. This combined study revealed that DUBs are
present in nearly every cellular compartment. Besides, stable
PPIs for over 55% of the DUBswere identified, including pre-
viously uncharacterized protein complexes essential for DUB
function, establishing these familymembers as bonafidedeu-
biquitinating enzymes. In another study, SILAC-based quan-
tification was performed for wild-type S. cerevisiae against 20
other strains in which DUBs had been systematically deleted
[95].Major changes in protein expression abundancewere ob-
served between individual deletion strains. These effects were
attributed to the direct influence of DUBs on their substrates,
as well as the indirect effects exerted via altered transcription.
5 Bioinformatic resources designed for
the analysis of ubiquitylation
So far, conventional databases such as Swiss-Prot [96] and
RESID [9] are two of the most highly curated sources for
PTMs. According to the Proteome-wide PTM Statistics Cu-
rator [97], there are currently 878 high quality, experimen-
tally observed Ub sites and 1594 putative Ub sites anno-
tated in the Swiss-Prot database. Meanwhile, PhosphoSite
Plus has already annotated 19 362 Ub sites [98]. On the
other hand, E3Net provides a comprehensive collection of
E3-substrate connections and a framework for the analysis of
E3-mediated regulatory networks [99]. Currently, E3Net con-
tains 2201E3s and 4896 substrates in 427 organisms and 1671
E3-substrate specific relations between 493 E3s and 1277 sub-
strates in 42 organisms. Likewise,S.CerevisiaeUbiquitination
Database [100] and Database of Plants Ubiquitin Proteasome
System (plantsUPS) [101] are specifically designed for stor-
ing information for the ubiquitin-proteasome system in yeast
and higher plants, respectively. In addition to providing re-
liable information to assist researchers in data-mining and
analysis, collection of highly curated data can also serve as
training datasets to help build new bioinformatics tools for
predicting Ub sites, motifs, or ligase–substrate relationship.
Some of these tools are E3Miner [102], UbiPred [103], and
UbPred [104].
6 Conclusion and future perspectives
Here we reviewed how an arsenal of MS-based tools is
now enhancing our understanding of different aspects of
ubiquitin-regulated biology. Finally, we outline below several
pending issues, which may be addressed by high-throughput
MS in the near future:
(i) The ability to generate high-density ubiquitomics data
[33–36] will allow the examination of positive and nega-
tive crosstalk between ubiquitylation and other PTMs
such as phosphorylation and Lys-acetylation where
dense data have already been acquired [105].
(ii) Despite earlier studies indicated the absence of se-
quencemotifs for ubiquitylation [19,20,33], two indepen-
dent, large-scale studies demonstrated respectively, the
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enrichment for nonpolar amino acids [34] and acidic
amino acids [35] surrounding the di-Gly-modified
lysines. A subsequent study implies that these sequence
biases can be partially explained by the different sources
of anti-di-Gly antibodies used [36]. More upcoming data
should help resolve this pending discrepancy.
(iii) Due to its omnipresence in cells, the ubiquitin net-
work is tightly regulated at every level. For instance,
some of the E2 and E3 enzymes are expressed in a
tissue-specificmanner, while others are compartmental-
ized within specific subcellular structures [106]. Besides,
many E3-DUB pairs work closely together to fine-tune
the timing of ubiquitin loading and removal. All these
different mechanisms of regulation can be studied by
spatiotemporal proteomics [107].
AlthoughMS-based proteomics provides valuable insights
for Ub-sites, chain linkages and possible network relation-
ship, classical biochemical assays, andmolecular biology tools
such as in vitro ubiquitylation assays and site-directed mu-
tagenesis remain indispensable for ubiquitin research since
they are crucial for validating proteomics data and for probing
the diverse influences of ubiquitylation on the biological sys-
tems investigated. The pace at which MS-based proteomics
is developing is astonishing. As for unraveling the biology of
ubiquitin network biology, the work reviewed here represents
just a beginning, rather than an end to this challenging and
important field.
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